Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.
about
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.The Intersection of TNF, IBD and the Microbiome.Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD.Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation.Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model.Acute severe ulcerative colitis: from pathophysiology to clinical management.GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation.Protective effects of Fc-fused PD-L1 on two different animal models of colitis.Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis.Obstructive Lymphangitis Precedes Colitis in Murine Norovirus-Infected Stat1-Deficient Mice.Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease.
P2860
Q34518822-CA5D7EDA-5AF5-4818-A3CC-49A9927E1BFCQ35945255-15E7F479-E96E-4458-BD7B-D6027FF73087Q36243481-15660636-658E-4B48-B9D7-73A532E583FAQ36303508-90851D95-B6E5-4462-814E-23A8C24E99F7Q36530839-3BB7A628-27CC-4ED8-A75F-6961321C405DQ38942561-6542BC7F-2462-4090-A6F1-2D9C6A919CB1Q39473017-033B925C-730D-4C4F-8440-1AFF91CD9B48Q42214211-EB42BEC7-D1FD-4EDD-ACD8-481CA672D5A8Q53255485-07FFE258-BE76-4342-855A-086CE250109EQ54213681-1675C9E0-5D3D-46F3-A691-9F4D032220CDQ55363309-635D0697-94A8-4329-8021-80DF73110D2D
P2860
Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@ast
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@en
type
label
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@ast
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@en
prefLabel
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@ast
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@en
P2093
P2860
P356
P1476
Pharmacological Evaluation of ...... As a Model of Crohn's Disease.
@en
P2093
Helle Markholst
Steen Seier Poulsen
Stine Reedtz-Runge
Thomas Lindebo Holm
P2860
P304
P356
10.1155/2012/412178
P577
2012-02-19T00:00:00Z